What role, if any, does vitamin D play in the development of diabetes or diabetic complications?
Reproductive History and Type 2 Diabetes Risk
A prospective cohort analysis suggests that the length of a woman’s reproductive period has an impact on risk of type 2 diabetes.
Glucose-Lowering Drugs, Diabetes, & CV Mortality
A study examined the risk of CV or all-cause mortality associated with glucose-lowering drugs taken alone or in combination for type 2 diabetes.
Celiac Disease & Diabetes: Who’s Most at Risk?
A large study of celiac disease looked at prevalence of T1DM and T2DM, and health risks associated with having both celiac disease and diabetes.
High Risk Periods for Hypoglycemia
Researchers explored seasonal variations in hypoglycemia and compared differences in type 1 diabetes and type 2 diabetes.
Interesting Endo: Sedentary Risks & Heart Health
Our August list of news and research includes research concerning a sedentary lifestyle, FDA updates, and imaging after thyroid cancer treatment.
Empagliflozin Linked to Improved Albuminuria
SGLT2 inhibition has been shown to preserve renal function and decrease albuminuria in animal models, but do these results apply to humans?
Do SGLT2 Inhibitors Really Increase Fracture Risk?
A new meta-analysis delved further into the topic of fracture risk with SGLT2 inhibitors. Was new evidence uncovered?
Industry Influence on Prescribing Rates
In this Medical News Minute, Dr. Bobby Lazzara looks at pharmacy industry-sponsored meals and rates of prescribing the promoted drug.
Microvascular Disease Burden in Type 2 Diabetes
Does microvascular disease burden predict future cardiovascular events in type 2 diabetes? Dr. Bobby Lazzara discusses this question.
Bariatric Surgery and Diabetes Guidelines
In this Medical News Minute, Dr. Bobby Lazzara discusses the findings of the 2nd Diabetes Surgery Summit regarding bariatric surgery and diabetes.
Reversing Type 2 Diabetes
In this Medical News Minute, Dr. Bobby Lazzara summarizes a study on the effects of a very-low-calorie diet on blood glucose.
Interesting Endo: Drug Trials & Cardio Health
Our July list of news and research includes LEADER and EMPA-REG trial results, kidney and cardiovascular health, and cognitive issues.
Understanding SGLT2 Inhibitors
This slideshow highlights several studies regarding the effects of SGLT2 inhibitors, which were presented at the 2016 ADA Scientific Sessions.
Beyond Basal Insulin in Type 2 Diabetes
Several studies presented at ADA 2016 discussed going beyond basal insulin treatments for patients with type 2 diabetes.
By clicking Accept, you agree to become a member of the UBM Medica Community.